[1] ZHOU M G, WANG H D, ZENG X Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158. doi:  10.1016/S0140-6736(19)30427-1
[2] 殷鹏, 齐金蕾, 刘韫宁, 等. 2005—2017年中国疾病负担研究报告[J]. 中国循环杂志, 2019, 34(12):1145-1154. doi:  10.3969/j.issn.1000-3614.2019.12.001
[3] SONG W J, KANG M G, CHANG Y S, et al. Epidemiology of adult asthma in Asia: toward a better understanding[J]. Asia Pac Allergy, 2014, 4(2):75-85. doi:  10.5415/apallergy.2014.4.2.75
[4] MORANTES-CABALLERO J A, FAJARDO RODRIGUEZ H A. Effects of air pollution on acute exacerbation of chronic obstructive pulmonary disease: a descriptive retrospective study (pol-AECOPD)[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:1549-1557. doi:  10.2147/COPD.S192047
[5] Global Initiative for Asthma. Global strategy for asthma management and prevention [EB/OL]. [2018-01-03]. http: / /www. goldcopd. org/.
[6] 李凡, 孙惠芬, 段静, 等. 从GOLD指南的演变看慢性阻塞性肺疾病的防治[J]. 中国全科医学, 2019, 22(27):3275-3280.
[7] GBD CHRONIC RESPIRATORY DISEASE COLLABORATORS. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet Respir Med, 2017, 5(9):691-706. doi:  10.1016/S2213-2600(17)30293-X
[8] HUANG K W, YANG T, XU J Y, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394(10196):407-418. doi:  10.1016/S0140-6736(19)31147-X
[9] 王西华, 骆益民, 杨远, 等. 哮喘患者MDI和都保吸入技术的调查以及健康教育对其的影响[J]. 东南大学学报(医学版), 2005, 24(6):389-391.
[10] 郑则广, 游一中, 康健, 等. 稳定期慢性气道疾病吸入装置规范应用中国专家共识[J]. 中华结核和呼吸杂志, 2019, 42(4):241-253. doi:  10.3760/cma.j.issn.1001-0939.2019.04.001
[11] 赵文敏, 杨毅, 田侃. 美国药物治疗管理模式对我国基层医疗机构药学服务能力建设的启示[J]. 中国新药杂志, 2019, 28(11):1292-1296.
[12] 国家卫生健康委办公厅. 关于印发医疗机构药学门诊服务规范等5项规范的通知(国卫办医函〔2021〕520号)[EB/OL]. (2021-10-9). http://www.nhc.gov.cn/yzygj/s7659/202110/f76fc77acd87458f950c86d7bc468f22.shtml.
[13] CHRYSTYN H, VAN DER PALEN J, SHARMA R, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis[J]. NPJ Prim Care Respir Med, 2017, 27(1):22. doi:  10.1038/s41533-017-0016-z
[14] MORISKY D E, ANG A, KROUSEL-WOOD M, et al. Predictive validity of a medication adherence measure in an outpatient setting[J]. J Clin Hypertens, 2008, 10(5):348-354. doi:  10.1111/j.1751-7176.2008.07572.x
[15] NATHAN R A, SORKNESS C A, KOSINSKI M, et al. Development of the asthma control test: a survey for assessing asthma control[J]. J Allergy Clin Immunol, 2004, 113(1):59-65. doi:  10.1016/j.jaci.2003.09.008
[16] 柴晶晶, 柳涛, 蔡柏蔷. 慢性阻塞性肺疾病评估测试中文版临床应用意义的评价[J]. 中华结核和呼吸杂志, 2011, 34(4):256-258. doi:  10.3760/cma.j.issn.1001-0939.2011.04.009
[17] 汪皖青, 周良, 陈蓉. 哮喘和慢性阻塞性肺疾病患者特色药学服务模式实践[J]. 医药导报, 2020, 39(12):1735-1741.
[18] 陈荣昌, 魏理, 郑则广. 稳定期慢性阻塞性肺疾病医药共管专家共识[J]. 中华结核和呼吸杂志, 2022, 45(10):980-987. doi:  10.3760/cma.j.cn112147-20220413-00316
[19] Rogliani P, Ora J, Puxeddu E, et al. Adherence to COPD treatment: Myth and reality[J]. Respir Med, 2017, 129:117-123. doi:  10.1016/j.rmed.2017.06.007
[20] PRICE A, VASANTHAN L, CLARKE M, et al. SMOOTH: Self-Management of Open Online Trials in Health analysis found improvements were needed for reporting methods of Internet-based trials[J]. J Clin Epidemiol, 2019, 105:27-39. doi:  10.1016/j.jclinepi.2018.08.017
[21] 李静, 李静婷, 姚伟珉, 等. 新型药学服务模式探索: 某院开设医师-药师哮喘慢病管理联合门诊的现状及成效[J]. 中南药学, 2020, 18(1):158-162.